{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T16:30:04Z","timestamp":1793464204393,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004507","name":"Central Drug Research Institute","doi-asserted-by":"publisher","award":["CII7041"],"award-info":[{"award-number":["CII7041"]}],"id":[{"id":"10.13039\/501100004507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nat Med"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s11418-026-02089-4","type":"journal-article","created":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T22:14:21Z","timestamp":1791152061000},"page":"1843-1860","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A standardized fraction of Cajanus scarabaeoides attenuates diabetic nephropathy via antiglycation, anti-inflammatory, and anti-fibrotic mechanisms"],"prefix":"10.1007","volume":"80","author":[{"given":"Rahul","family":"Baghel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind K.","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preety","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishbal","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhav N.","family":"Mugale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Kanojiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilesh K.","family":"Tamrakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"issue":"1","key":"2089_CR1","doi-asserted-by":"publisher","first-page":"e030821192146","DOI":"10.2174\/1573399817666210309104203","volume":"18","author":"K Nellaiappan","year":"2022","unstructured":"Nellaiappan K, Preeti K, Khatri DK, Singh SB (2022) Diabetic complications: An update on pathobiology and therapeutic strategies. Curr Diabetes Rev 18(1):e030821192146. https:\/\/doi.org\/10.2174\/1573399817666210309104203","journal-title":"Curr Diabetes Rev"},{"issue":"7","key":"2089_CR2","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.3390\/ijms26073330","volume":"26","author":"Y Ratan","year":"2025","unstructured":"Ratan Y, Rajput A, Pareek A, Pareek A, Singh G (2025) Comprehending the role of metabolic and hemodynamic factors alongside different signaling pathways in the pathogenesis of diabetic nephropathy. Int J Mol Sci 26(7):3330. https:\/\/doi.org\/10.3390\/ijms26073330","journal-title":"Int J Mol Sci"},{"key":"2089_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2147\/IJNRD.S40172","volume":"7","author":"AK Lim","year":"2014","unstructured":"Lim AK (2014) Diabetic nephropathy-complications and treatment. Int J Nephrol Renovasc Dis 7:361. https:\/\/doi.org\/10.2147\/IJNRD.S40172","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"12","key":"2089_CR4","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.2337\/dci22-0027","volume":"45","author":"IH de Boer","year":"2022","unstructured":"de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, Rosas SE, Rossing P, Bakris G (2022) Diabetes management in chronic kidney disease: A consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care 45(12):3075. https:\/\/doi.org\/10.2337\/dci22-0027","journal-title":"Diabetes Care"},{"key":"2089_CR5","doi-asserted-by":"publisher","first-page":"1602594","DOI":"10.3389\/fendo.2025.1602594","volume":"16","author":"G Hou","year":"2025","unstructured":"Hou G, Dong Y, Jiang Y, Zhao W, Zhou L, Cao S, Li W (2025) Immune inflammation and metabolic interactions in the pathogenesis of diabetic nephropathy. Front Endocrinol (Lausanne 16:1602594. https:\/\/doi.org\/10.3389\/fendo.2025.1602594","journal-title":"Front Endocrinol (Lausanne"},{"issue":"4","key":"2089_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3390\/antiox13040455","volume":"13","author":"N Wang","year":"2024","unstructured":"Wang N, Zhang C (2024) Oxidative Stress: A culprit in the progression of diabetic kidney disease. Antioxid (Basel) 13(4):455. https:\/\/doi.org\/10.3390\/antiox13040455","journal-title":"Antioxid (Basel)"},{"key":"2089_CR7","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.mce.2017.01.009","volume":"443","author":"YY Qiu","year":"2017","unstructured":"Qiu YY, Tang LQ, Wei W (2017) Berberine exerts renoprotective effects by regulating the AGEs-RAGE signaling pathway in mesangial cells during diabetic nephropathy. Mol Cell Endocrinol 443:89. https:\/\/doi.org\/10.1016\/j.mce.2017.01.009","journal-title":"Mol Cell Endocrinol"},{"issue":"13","key":"2089_CR8","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.3390\/nu14132675","volume":"14","author":"AK Fotheringham","year":"2022","unstructured":"Fotheringham AK, Gallo LA, Borg DJ, Forbes JM (2022) Advanced glycation end products (AGEs) and chronic kidney disease: does the modern diet AGE the kidney? Nutrients 14(13):2675. https:\/\/doi.org\/10.3390\/nu14132675","journal-title":"Nutrients"},{"key":"2089_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejphar.2018.06.001","volume":"833","author":"D Sanajou","year":"2018","unstructured":"Sanajou D, Ghorbani Haghjo A, Argani H, Aslani S (2018) AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions. Eur J Pharmacol 833:158. https:\/\/doi.org\/10.1016\/j.ejphar.2018.06.001","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"2089_CR10","doi-asserted-by":"publisher","first-page":"151431","DOI":"10.1016\/j.semnephrol.2023.151431","volume":"43","author":"Y Oda","year":"2023","unstructured":"Oda Y, Nishi H, Nangaku M (2023) Role of inflammation in progression of chronic kidney disease in type 2 diabetes mellitus: Clinical implications. Semin Nephrol 43(3):151431. https:\/\/doi.org\/10.1016\/j.semnephrol.2023.151431","journal-title":"Semin Nephrol"},{"issue":"3","key":"2089_CR11","doi-asserted-by":"publisher","first-page":"393","DOI":"10.4239\/wjd.v5.i3.393","volume":"5","author":"MB Duran-Salgado","year":"2014","unstructured":"Duran-Salgado MB, Rubio-Guerra AF (2014) Diabetic nephropathy and inflammation. World J Diabetes 5(3):393. https:\/\/doi.org\/10.4239\/wjd.v5.i3.393","journal-title":"World J Diabetes"},{"issue":"6","key":"2089_CR12","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"XM Meng","year":"2016","unstructured":"Meng XM, Nikolic-Paterson DJ, Lan HY (2016) TGF-\u03b2: the master regulator of fibrosis. Nat Rev Nephron 12(6):325. https:\/\/doi.org\/10.1038\/nrneph.2016.48","journal-title":"Nat Rev Nephron"},{"issue":"1","key":"2089_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2478\/dine-2021-0005","volume":"1","author":"DM Patel","year":"2021","unstructured":"Patel DM, Yang Y, Shi K, Wu Tieqiao C, Mark E, Chai Z (2021) Key profibrotic and pro-inflammatory pathways in the pathogenesis of diabetic kidney disease. Diabet Nephrop 1(1):15\u201326","journal-title":"Diabet Nephrop"},{"issue":"1","key":"2089_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.2174\/138945011793591626","volume":"12","author":"T Efferth","year":"2011","unstructured":"Efferth T, Koch E (2011) Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy. Curr Drug Targets 12(1):122. https:\/\/doi.org\/10.2174\/138945011793591626","journal-title":"Curr Drug Targets"},{"key":"2089_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-70638-2","volume-title":"Indian medicinal plants-an illustrated dictionary","author":"CP Khare","year":"2007","unstructured":"Khare CP (2007) Indian medicinal plants-an illustrated dictionary. Springer, New York"},{"issue":"2","key":"2089_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.18311\/jnr\/2010\/251","volume":"10","author":"S Pattanayak","year":"2010","unstructured":"Pattanayak S, Nayak SS, Panda D, Pansare A, Shende V (2010) Pharmacological investigation of Cajanus scarabaeoides in different animal models of diarrhoea. J Nat Rem 10(2):109. https:\/\/doi.org\/10.18311\/jnr\/2010\/251","journal-title":"J Nat Rem"},{"key":"2089_CR17","volume-title":"CRC world dictionary of medicinal and poisonous plants","author":"U Quattrocchi","year":"2012","unstructured":"Quattrocchi U (2012) CRC world dictionary of medicinal and poisonous plants. CRC, New York"},{"issue":"12","key":"2089_CR18","doi-asserted-by":"publisher","first-page":"e0208201","DOI":"10.1371\/journal.pone.0208201","volume":"13","author":"AS Ray","year":"2018","unstructured":"Ray AS, Joardar N, Mukherjee S, Rahaman CH, Sinha Babu SP (2018) Polyphenol enriched ethanolic extract of Cajanus scarabaeoides (L.) Thouars exerts potential antifilarial activity by inducing oxidative stress and programmed cell death. PLoS ONE 13(12):e0208201. https:\/\/doi.org\/10.1371\/journal.pone.0208201","journal-title":"PLoS ONE"},{"issue":"3","key":"2089_CR19","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11130-025-01362-3","volume":"80","author":"R Rokkam","year":"2025","unstructured":"Rokkam R, Pinipay F, Killo JT, Botcha S, Tamanam RR (2025) Nutritional characterization and metabolic profiling of bioactive compounds in Cajanus scarabaeoides seeds using GC-MS and LC-MS analysis. Plant Foods Hum Nutr 80(3):121. https:\/\/doi.org\/10.1007\/s11130-025-01362-3","journal-title":"Plant Foods Hum Nutr"},{"key":"2089_CR20","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1017\/jns.2016.41","volume":"5","author":"AN Panche","year":"2016","unstructured":"Panche AN, Diwan AD, Chandra SR (2016) Flavonoids: an overview. J Nutr Sci 5:e47. https:\/\/doi.org\/10.1017\/jns.2016.41","journal-title":"J Nutr Sci"},{"issue":"1","key":"2089_CR21","first-page":"120","volume":"10","author":"AS Ray","year":"2018","unstructured":"Ray AS, Rahaman CH (2018) Pharmacognostic standardization and phytochemical investigation of Cajanus scarabaeoides (L.) Thouars. Res J Pharmacognosy Phytochem 10(1):120\u2013131. doi.org\/10.598\/0975-4385.2018.00018.3","journal-title":"Res J Pharmacognosy Phytochem"},{"issue":"22","key":"2089_CR22","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1039\/d5ay00398a","volume":"17","author":"AK Maurya","year":"2025","unstructured":"Maurya AK, Tanwar AS, Mishra DK, Kanojiya S (2025) Structural characterization and quantification of isomeric bioactive flavonoid C-glycosides utilizing high-performance liquid chromatography coupled with diode array detection and mass spectrometry. Anal Methods 17(22):4607. https:\/\/doi.org\/10.1039\/d5ay00398a","journal-title":"Anal Methods"},{"issue":"17","key":"2089_CR23","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1080\/14786419.2019.1672690","volume":"35","author":"AK Rai","year":"2021","unstructured":"Rai AK, Singh SP, Pandey AR, Ansari A, Ahmad S, Sashidhara KV, Tamrakar AK (2021) Flavonoids from Polyalthia longifolia prevents advanced glycation end products formation and protein oxidation aligned with fructose-induced protein glycation. Nat Prod Res 35(17):2921. https:\/\/doi.org\/10.1080\/14786419.2019.1672690","journal-title":"Nat Prod Res"},{"issue":"5","key":"2089_CR24","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3390\/antiox12051052","volume":"12","author":"C Ram","year":"2023","unstructured":"Ram C, Gairola S, Verma S, Mugale MN, Bonam SR, Murty US, Sahu BD (2023) Biochanin A ameliorates nephropathy in high-fat diet\/streptozotocin-induced diabetic rats: Effects on NF-kB\/NLRP3 axis, pyroptosis, and fibrosis. Antioxid (Basel) 12(5):1052. https:\/\/doi.org\/10.3390\/antiox12051052","journal-title":"Antioxid (Basel)"},{"key":"2089_CR25","doi-asserted-by":"publisher","first-page":"122064","DOI":"10.1016\/j.lfs.2023.122064","volume":"331","author":"KR Washimkar","year":"2023","unstructured":"Washimkar KR, Tomar MS, Kulkarni C, Verma S, Shrivastava A, Chattopadhyay N, Mugale MN (2023) Longitudinal assessment of bleomycin-induced pulmonary fibrosis by evaluating TGF-\u03b21\/Smad2, Nrf2 signaling and metabolomic analysis in mice. Life Sci 331:122064. https:\/\/doi.org\/10.1016\/j.lfs.2023.122064","journal-title":"Life Sci"},{"issue":"1","key":"2089_CR26","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3945\/an.116.013912","volume":"8","author":"A Gugliucci","year":"2017","unstructured":"Gugliucci A (2017) Formation of fructose-mediated advanced glycation end products and their roles in metabolic and inflammatory diseases. Adv Nutr 8(1):54. https:\/\/doi.org\/10.3945\/an.116.013912","journal-title":"Adv Nutr"},{"issue":"1","key":"2089_CR27","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1152\/physrev.00001.2019","volume":"100","author":"CG Schalkwijk","year":"2020","unstructured":"Schalkwijk CG, Stehouwer CDA (2020) Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases. Physiol Rev 100(1):407. https:\/\/doi.org\/10.1152\/physrev.00001.2019","journal-title":"Physiol Rev"},{"issue":"1","key":"2089_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s13659-024-00446-y","volume":"14","author":"B Huang","year":"2024","unstructured":"Huang B, Han R, Tan H, Zhu W, Li Y, Jiang F, Xie C, Ren Z, Shi R (2024) Scutellarin ameliorates diabetic nephropathy via TGF-\u03b21 signaling pathway. Nat Prod Bioprospect 14(1):25. https:\/\/doi.org\/10.1007\/s13659-024-00446-y","journal-title":"Nat Prod Bioprospect"},{"issue":"20","key":"2089_CR29","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","volume":"329","author":"EJ Lewis","year":"1993","unstructured":"Lewis EJ, Hunsicker LG, Bain RP, Rohde RD (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group. N Engl J Med 329(20):1456\u20131462. https:\/\/doi.org\/10.1056\/NEJM199311113292004","journal-title":"N Engl J Med"},{"issue":"1","key":"2089_CR30","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s13098-025-01726-4","volume":"17","author":"EE Efiong","year":"2025","unstructured":"Efiong EE, Maedler K, Effa E, Osuagwu UL, Peters E, Ikebiuro JO, Soremekun C, Ihediwa U, Niu J, Fuchs M, Bazireh H, Bassey AL, Amadi PU, Dong Q, Kimani NM, Chukwuanukwu RC, Tuenter E, Sharma S, Grallert H (2025) Decoding diabetic kidney disease: a comprehensive review of interconnected pathways, molecular mediators, and therapeutic insights. Diabetol Metab Syndr 17(1):192. https:\/\/doi.org\/10.1186\/s13098-025-01726-4","journal-title":"Diabetol Metab Syndr"},{"issue":"2","key":"2089_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1053\/j.jrn.2023.09.005","volume":"34","author":"L Ding","year":"2024","unstructured":"Ding L, Hou Y, Liu J, Wang X, Wang Z, Ding W, Zhao K (2024) Circulating concentrations of advanced glycation end products, carboxymethyl lysine and methylglyoxal are associated with renal function in individuals with diabetes. J Ren Nutr 34(2):154. https:\/\/doi.org\/10.1053\/j.jrn.2023.09.005","journal-title":"J Ren Nutr"},{"issue":"24","key":"2089_CR32","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.1080\/14786419.2022.2025799","volume":"36","author":"S Ahmad","year":"2022","unstructured":"Ahmad S, Pandey AR, Singh SP, Singh S, Sashidhara KV, Tamrakar AK (2022) Antiglycation activity of \u03b2-glucogallin from Asparagus racemosus. Nat Prod Res 36(24):6329. https:\/\/doi.org\/10.1080\/14786419.2022.2025799","journal-title":"Nat Prod Res"},{"issue":"10","key":"2089_CR33","doi-asserted-by":"publisher","first-page":"946","DOI":"10.2174\/138161208784139710","volume":"14","author":"K Fukami","year":"2008","unstructured":"Fukami K, Yamagishi S, Ueda S, Okuda S (2008) Role of AGEs in diabetic nephropathy. Curr Pharm Des 14(10):946. https:\/\/doi.org\/10.2174\/138161208784139710","journal-title":"Curr Pharm Des"},{"key":"2089_CR34","doi-asserted-by":"publisher","first-page":"156046","DOI":"10.1016\/j.phymed.2024.156046","volume":"135","author":"D Zhu","year":"2024","unstructured":"Zhu D, Ni Y, Chen C, Dong Z, Wang L, Zhang W (2024) Geniposide ameliorates diabetic nephropathy in type 2 diabetic mice by targeting AGEs-RAGE-dependent inflammatory pathway. Phytomedicine 135:156046. https:\/\/doi.org\/10.1016\/j.phymed.2024.156046","journal-title":"Phytomedicine"},{"issue":"6","key":"2089_CR35","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/01.mjt.0000178769.52610.69","volume":"12","author":"MC Thomas","year":"2005","unstructured":"Thomas MC, Forbes JM, Cooper ME (2005) Advanced glycation end products and diabetic nephropathy. Am J Ther 12(6):562. https:\/\/doi.org\/10.1097\/01.mjt.0000178769.52610.69","journal-title":"Am J Ther"},{"issue":"3","key":"2089_CR36","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1681\/ASN.2007091048","volume":"19","author":"JF Navarro-Gonz\u00e1lez","year":"2008","unstructured":"Navarro-Gonz\u00e1lez JF, Mora-Fern\u00e1ndez C (2008) The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 19(3):433. https:\/\/doi.org\/10.1681\/ASN.2007091048","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"2089_CR37","doi-asserted-by":"publisher","first-page":"e29871","DOI":"10.1016\/j.heliyon.2024.e29871","volume":"10","author":"A Rezaee","year":"2024","unstructured":"Rezaee A, Rahmanian P, Nemati A, Sohrabifard F, Karimi F, Elahinia A, Ranjbarpazuki A, Lashkarbolouki R, Dezfulian S, Zandieh MA, Salimimoghadam S, Nabavi N, Rashidi M, Taheriazam A, Hashemi M, Hushmandi K (2024) NF-\u0138B axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies. Heliyon 10(9):e29871. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e29871","journal-title":"Heliyon"},{"issue":"8","key":"2089_CR38","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/14728222.2022.2133698","volume":"26","author":"J Tang","year":"2022","unstructured":"Tang J, Liu F, Cooper ME, Chai Z (2022) Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-\u03b2) and related molecules. Expert Opin Ther Targets 26(8):721. https:\/\/doi.org\/10.1080\/14728222.2022.2133698","journal-title":"Expert Opin Ther Targets"},{"key":"2089_CR39","doi-asserted-by":"publisher","first-page":"179007","DOI":"10.1016\/j.ejphar.2026.179007","volume":"1029","author":"D Tang","year":"2026","unstructured":"Tang D, Liu Z, He Y, Liang S, Feng T, Ou G, Chen Y, Nong Q, Chen G, Zhang Q, Jiao Y, Chen Z (2026) Connexin32 inhibits renal tubulointerstitial fibrosis in diabetic kidney disease by regulating NOX4\/MRTF-A positive feedback loop. Eur J Pharmacol 1029:179007. https:\/\/doi.org\/10.1016\/j.ejphar.2026.179007","journal-title":"Eur J Pharmacol"},{"key":"2089_CR40","doi-asserted-by":"publisher","first-page":"117833","DOI":"10.1016\/j.bcp.2026.117833","volume":"248","author":"X Wang","year":"2026","unstructured":"Wang X, Wang H, Yan F, Li CL, Li BH, Gao JH, Chen BL, Li SP, Wang JH (2026) Dapagliflozin alleviates renal fibrosis in type 2 diabetic mice through regulating STAT3. Biochem Pharmacol 248:117833. https:\/\/doi.org\/10.1016\/j.bcp.2026.117833","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"2089_CR41","doi-asserted-by":"publisher","first-page":"e71712","DOI":"10.1096\/fj.202503456RR","volume":"40","author":"JJ Xiao","year":"2026","unstructured":"Xiao JJ, Li Y, Yang L, Chen HM, Hu JW, Hu BB, Lu Q, Cai H, Fan D, Wu X, Lu Z, Zhang BF (2026) Regulator of Calcineurin 1 aggravates tubular epithelial cell injury in diabetic mice through promoting liver kinase B1 ubiquitination. FASEB J 40(6):e71712. https:\/\/doi.org\/10.1096\/fj.202503456RR","journal-title":"FASEB J"},{"issue":"1","key":"2089_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.phrs.2009.02.002","volume":"60","author":"P Balakumar","year":"2009","unstructured":"Balakumar P, Arora MK, Ganti SS, Reddy J, Singh M (2009) Recent advances in pharmacotherapy for diabetic nephropathy: current perspectives and future directions. Pharmacol Res 60(1):24\u201332. https:\/\/doi.org\/10.1016\/j.phrs.2009.02.002","journal-title":"Pharmacol Res"},{"issue":"1","key":"2089_CR43","doi-asserted-by":"publisher","first-page":"2327495","DOI":"10.1080\/0886022X.2024.2327495","volume":"46","author":"L Zhang","year":"2024","unstructured":"Zhang L, Wang X, Chang L, Ren Y, Sui M, Fu Y, Zhang L, Hao L (2024) Quercetin improves diabetic kidney disease by inhibiting ferroptosis and regulating the Nrf2 in streptozotocin-induced diabetic rats. Ren Fail 46(1):2327495. https:\/\/doi.org\/10.1080\/0886022X.2024.2327495","journal-title":"Ren Fail"},{"key":"2089_CR44","doi-asserted-by":"publisher","first-page":"178255","DOI":"10.1016\/j.ejphar.2025.178255","volume":"1007","author":"S Ahmad","year":"2025","unstructured":"Ahmad S, Baghel R, Katiyar S, Kumar P, Yadav M, Chhikara N, Panwar D, Ahmad I, Mugale MN, Sashidhara KV, Tamrakar AK (2025) Protective effects of a 1,4-dihydropyridine-indole derivative against diabetic nephropathy via modulation of oxidative stress, inflammation, and fibrosis. Eur J Pharmacol 1007:178255. https:\/\/doi.org\/10.1016\/j.ejphar.2025.178255","journal-title":"Eur J Pharmacol"},{"key":"2089_CR45","doi-asserted-by":"publisher","first-page":"816400","DOI":"10.3389\/fendo.2022.816400","volume":"13","author":"J Yang","year":"2022","unstructured":"Yang J, Liu Z (2022) Mechanistic pathogenesis of endothelial dysfunction in diabetic nephropathy and retinopathy. Front Endocrinol (Lausanne) 13:816400. https:\/\/doi.org\/10.3389\/fendo.2022.816400","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2089_CR46","doi-asserted-by":"publisher","first-page":"F596","DOI":"10.1152\/ajprenal.00365.2015","volume":"310","author":"A Sureshbabu","year":"2016","unstructured":"Sureshbabu A, Muhsin SA, Choi ME (2016) TGF-\u03b2 signaling in the kidney: profibrotic and protective effects. Am J Physiol Ren Physiol 310(7):F596. https:\/\/doi.org\/10.1152\/ajprenal.00365.2015","journal-title":"Am J Physiol Ren Physiol"},{"key":"2089_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cellsig.2017.11.005","volume":"43","author":"SP Higgins","year":"2018","unstructured":"Higgins SP, Tang Y, Higgins CE, Mian B, Zhang W, Czekay RP, Samarakoon R, Conti DJ, Higgins PJ (2018) TGF-\u03b21\/p53 signaling in renal fibrogenesis. Cell Signal 43:1. https:\/\/doi.org\/10.1016\/j.cellsig.2017.11.005","journal-title":"Cell Signal"},{"key":"2089_CR48","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fcell.2020.00123","volume":"8","author":"YY Gu","year":"2020","unstructured":"Gu YY, Liu XS, Huang XR, Yu XQ, Lan HY (2020) Diverse role of TGF-\u03b2 in kidney disease. Front Cell Dev Biol 8:123. https:\/\/doi.org\/10.3389\/fcell.2020.00123","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2089_CR49","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/0886022X.2018.1496934","volume":"40","author":"Q Xiao","year":"2018","unstructured":"Xiao Q, Guan Y, Li C, Liu L, Zhao D, Wang H (2018) Decreased expression of transforming growth factor-\u03b21 and \u03b1-smooth muscle actin contributes to the protection of lotensin against chronic renal failure in rats. Ren Fail 40(1):583. https:\/\/doi.org\/10.1080\/0886022X.2018.1496934","journal-title":"Ren Fail"},{"issue":"5\u20136","key":"2089_CR50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1515\/bmc-2016-0021","volume":"7","author":"A Kumar Pasupulati","year":"2016","unstructured":"Kumar Pasupulati A, Chitra PS, Reddy GB (2016) Advanced glycation end products mediated cellular and molecular events in the pathology of diabetic nephropathy. Biomol Concepts 7(5\u20136):293. https:\/\/doi.org\/10.1515\/bmc-2016-0021","journal-title":"Biomol Concepts"}],"container-title":["Journal of Natural Medicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-026-02089-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11418-026-02089-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11418-026-02089-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:32:52Z","timestamp":1793460772000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11418-026-02089-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2089"],"URL":"https:\/\/doi.org\/10.1007\/s11418-026-02089-4","relation":{},"ISSN":["1340-3443","1861-0293"],"issn-type":[{"value":"1340-3443","type":"print"},{"value":"1861-0293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"assertion":[{"value":"20 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}